humans |
48 |
medical sciences |
36 |
adult |
33 |
female |
33 |
male |
33 |
middle aged |
30 |
covid-19 |
26 |
sars-cov-2 |
24 |
gastroenterology |
22 |
epidemiology |
21 |
colonoscopy |
20 |
adolescent |
17 |
sars-cov |
17 |
aspirin |
16 |
atrial fibrillation |
16 |
colorectal cancer |
16 |
helicobacter pylori |
16 |
cross-sectional studies |
15 |
hepatocellular carcinoma |
15 |
hong kong |
15 |
aged |
14 |
body mass index |
14 |
child |
14 |
complications |
14 |
coronavirus infection |
14 |
health outcomes |
14 |
immune activation |
14 |
intestine |
14 |
replication |
14 |
chinese |
13 |
cohort studies |
13 |
survival analysis |
13 |
body height |
12 |
elderly |
12 |
gastrointestinal bleeding |
12 |
artificial intelligence |
11 |
chemoprevention |
11 |
covid-19 vaccine |
11 |
gastric cancer |
11 |
inflammatory bowel disease |
11 |
advanced hcc |
10 |
advanced hepatocellular carcinoma |
10 |
autoimmune disorders |
10 |
child, preschool |
10 |
china |
10 |
double-blind method |
10 |
gastrointestinal haemorrhage |
10 |
metformin |
10 |
reference values |
10 |
sorafenib |
10 |
time in therapeutic range |
10 |
hepatitis |
9 |
prevalence |
9 |
adiponectin |
8 |
adiponectin - blood |
8 |
adverse events |
8 |
antibiotics |
8 |
carcinoma, hepatocellular - mortality - therapy |
8 |
chemoembolization, therapeutic - adverse effects - mortality |
8 |
child-pugh a |
8 |
child-pugh b |
8 |
cytology and histology |
8 |
enzyme-linked immunosorbent assay |
8 |
hong kong - epidemiology |
8 |
incidence |
8 |
infusions, intra-arterial |
8 |
liver neoplasms - mortality - therapy |
8 |
magnetic resonance imaging |
8 |
oncology medical sciences |
8 |
radiology and nuclear medicine pharmacy and pharmacology biology |
8 |
transarterial chemoembolization |
8 |
adenocarcinoma |
7 |
alkaline phosphatase |
7 |
asian continental ancestry group |
7 |
biliary |
7 |
biomarker |
7 |
body composition - physiology |
7 |
cholangiogram |
7 |
cohort study |
7 |
colon cancer |
7 |
crc |
7 |
down-regulation - physiology |
7 |
immortal time bias |
7 |
interval cancer |
7 |
intra-abdominal fat - physiopathology |
7 |
ketamine |
7 |
longitudinal studies |
7 |
magnetic resonance cholangiography |
7 |
mir-139-3p |
7 |
mir-622 |
7 |
mirna |
7 |
mortality |
7 |
nonsteroidal anti-inflammatory drugs |
7 |
obstructive sleep apnea |
7 |
prospective studies |
7 |
proton pump inhibitors |
7 |
risk assessment |
7 |
risk factors |
7 |
sleep apnea, obstructive - diagnosis - physiopathology |
7 |
stroke |
7 |
subcutaneous fat, abdominal - physiopathology |
7 |
substance abuse |
7 |
sympathetic activity |
7 |
sympathetic nervous system - physiopathology |
7 |
tumor markers, biological - analysis |
7 |
type 2 diabetes mellitus |
7 |
antipsychotic agents - therapeutic use |
6 |
bevacizumab |
6 |
blood pressure |
6 |
body weight |
6 |
chemotherapy |
6 |
clinical trials |
6 |
colon neoplasms |
6 |
curative colectomy |
6 |
dabigatran |
6 |
dibenzothiazepines - therapeutic use |
6 |
erlotinib |
6 |
follow up |
6 |
gastrointestinal tumours |
6 |
hospitalization |
6 |
infant |
6 |
meta-analysis |
6 |
point mutation - genetics |
6 |
preventive medicine |
6 |
primary care |
6 |
prognosis |
6 |
psychotic disorders - drug therapy |
6 |
recurrence |
6 |
rivaroxaban |
6 |
sorafenib-refractory |
6 |
stomach cancer |
6 |
time factors |
6 |
ulcerative colitis |
6 |
warfarin |
6 |
young adult |
6 |
aged, 80 and over |
5 |
alpha-fetoprotein |
5 |
angiotensin-converting enzyme inhibitors |
5 |
anticoagulant |
5 |
bacteria |
5 |
bleeding |
5 |
cancer incidence |
5 |
cancer risk |
5 |
carcinoma, hepatocellular - diagnosis - mortality |
5 |
carrier proteins - genetics |
5 |
case-control studies |
5 |
cholesterol - blood |
5 |
clopidogrel |
5 |
cohort analysis |
5 |
colonic adenoma. |
5 |
colonic neoplasms |
5 |
colonic polyp |
5 |
colorectal polyp |
5 |
comorbidity |
5 |
crohn's disease |
5 |
dyspepsia |
5 |
endocuff |
5 |
endoscopic retrograde cholangiopancreatography |
5 |
endoscopic sphicterotomy |
5 |
esomeprazole |
5 |
fecal-to-oral transmission |
5 |
forced expiratory volume - physiology |
5 |
gastroesophageal reflux |
5 |
gastrointestinal hemorrhage |
5 |
hippo signaling |
5 |
infant, newborn |
5 |
intestinal metaplasia |
5 |
length |
5 |
liver neoplasms - diagnosis - mortality |
5 |
methylation |
5 |
noncardiac chest pain |
5 |
non–vitamin k antagonist oral anticoagulants |
5 |
nsaid |
5 |
nuclear proteins - analysis |
5 |
outcome |
5 |
overall survival |
5 |
papillotomy |
5 |
pilot projects |
5 |
post‐colonoscopy colorectal cancer |
5 |
prediction model |
5 |
prisma |
5 |
prognostic marker |
5 |
propensity score |
5 |
quality of life |
5 |
questionnaires |
5 |
readmission |
5 |
real‐life |
5 |
renin |
5 |
respiratory diseases |
5 |
roc curve |
5 |
sars |
5 |
severity of illness index |
5 |
surrogate |
5 |
tace |
5 |
transcription factors - analysis |
5 |
treatment outcome |
5 |
triple therapy |
5 |
tumor recurrence |
5 |
viral persistence |
5 |
yes-associated protein |
5 |
13c-urea breath test |
4 |
adverse outcome |
4 |
age distribution |
4 |
ageaged |
4 |
aging |
4 |
albuminuria - physiopathology |
4 |
antibodies, bacterial - blood |
4 |
antiplatelet |
4 |
antiplatelet drugs |
4 |
anxiety - psychology |
4 |
audiovisual aids |
4 |
beta-thalassemia - physiopathology |
4 |
bioinformatics |
4 |
biological markers - blood |
4 |
bmi |
4 |
breathing exercises |
4 |
calcium channel blockers |
4 |
cardiology - education |
4 |
cardiovascular diseases - metabolism - physiopathology |
4 |
catch-up growth |
4 |
chi-square distribution |
4 |
child development |
4 |
children |
4 |
china - epidemiology |
4 |
china - ethnology |
4 |
circadian rhythm |
4 |
codon - genetics |
4 |
colorectal neoplasms |
4 |
comprehension |
4 |
continuous positive airway pressure |
4 |
coronavirus |
4 |
crc patients |
4 |
depression - psychology |
4 |
diagnostic biomarker |
4 |
drug use |
4 |
education, medical, undergraduate |
4 |
educational status |
4 |
exercise |
4 |
exercise therapy |
4 |
experimental design |
4 |
gastric adenocarcinoma |
4 |
gastroscopy |
4 |
growth - physiology |
4 |
growth curve |
4 |
h pylori |
4 |
health economics |
4 |
health knowledge, attitudes, practice |
4 |
health status |
4 |
health surveys |
4 |
heart rate |
4 |
helicobacter pylori - immunology - isolation & purification |
4 |
helicobacter pylori - treatment |
4 |
helicobacterpylori |
4 |
hepatitis b |
4 |
hpv vaccine |
4 |
hpv vaccine perception |
4 |
hpv vaccine questionnaire |
4 |
hpv vaccine survey |
4 |
human papillomavirus |
4 |
hypertension - physiopathology - psychology - therapy - urine |
4 |
insulin - metabolism |
4 |
insulin sensitivity |
4 |
karyotype |
4 |
latency interval |
4 |
lupus erythematosus, systemic - epidemiology - genetics |
4 |
malignancy |
4 |
mannose-binding lectins |
4 |
metagenomics |
4 |
microbiome |
4 |
micrornas - physiology |
4 |
nafld |
4 |
nasal continuous positive airway pressure |
4 |
next generation sequencing |
4 |
nf-kappa b - physiology |
4 |
obstructive sleep apnoea |
4 |
oral anticoagulant |
4 |
oxygen - metabolism |
4 |
papillomaviridae - immunology |
4 |
papillomavirus infections - prevention & control - virology |
4 |
papillomavirus vaccines |
4 |
patient simulation |
4 |
peptic ulcer |
4 |
pharmacoepidemiology |
4 |
ppi |
4 |
prevention |
4 |
psychiatric status rating scales |
4 |
puberty, delayed |
4 |
qigong |
4 |
randomised controlled trial |
4 |
receptors, prostaglandin e, ep2 subtype - physiology |
4 |
receptors, prostaglandin e, ep4 subtype - physiology |
4 |
rectal cancer |
4 |
regression analysis |
4 |
renin - blood |
4 |
retrospective studies |
4 |
serum microrna (mirna) |
4 |
sex distribution |
4 |
shock - metabolism - physiopathology |
4 |
sleep apnea, obstructive - metabolism - therapy |
4 |
staging |
4 |
stomach |
4 |
stomach neoplasms - pathology |
4 |
students, medical |
4 |
surgery |
4 |
teaching - methods |
4 |
thinness |
4 |
thiopurine |
4 |
thiopurines |
4 |
time trend |
4 |
turner's syndrome |
4 |
uterine cervical neoplasms - prevention & control - virology |
4 |
vaccine |
4 |
weight |
4 |
3-month overall survival |
3 |
5-ht3 receptor antagonist |
3 |
adenocarcinoma - metabolism |
3 |
advanced liver cancer prognostic system |
3 |
age |
3 |
age factors |
3 |
analgesia |
3 |
anti-ulcer agents - therapeutic use |
3 |
antiemetic |
3 |
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
3 |
area under curve |
3 |
artificial ventilation |
3 |
bioimpedance |
3 |
bismuth - therapeutic use |
3 |
bone density - physiology |
3 |
bone mass density |
3 |
bronchiectasis - immunology - microbiology |
3 |
bungarotoxins - pharmacology |
3 |
c-reactive protein |
3 |
c-reactive protein - metabolism |
3 |
cancer |
3 |
carboplatin |
3 |
carcinogens - toxicity |
3 |
carrier proteins - blood |
3 |
caucasian |
3 |
cell line, tumor |
3 |
cell proliferation - drug effects |
3 |
cerebrovascular accident |
3 |
chemicals and cas registry numbers |
3 |
childhood |
3 |
childhood diabetes |
3 |
chronic obstructive pulmonary disease |
3 |
clinical trials. |
3 |
covid-19 infection |
3 |
cox-2 |
3 |
cyclin d1 - metabolism |
3 |
cyclooxygenase 2 - drug effects - metabolism |
3 |
data collection |
3 |
development |
3 |
dexamethasone |
3 |
diagnosis |
3 |
dinoprostone - metabolism |
3 |
direct thrombin inhibitor |
3 |
disease outbreaks |
3 |
disease-free survival |
3 |
dose-response relationship, drug |
3 |
drug side effect |
3 |
drug therapy, combination - therapeutic use |
3 |
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
dual-energy x-ray absorptiometry |
3 |
dyspepsia - microbiology |
3 |
electric impedance |
3 |
european continental ancestry group |
3 |
factor xa inhibitor |
3 |
fetal blood - chemistry |
3 |
follow-up studies |
3 |
forced expiratory volume |
3 |
functional residual capacity |
3 |
gastric carcinoma |
3 |
gastric dysplasia |
3 |
gene expression regulation - drug effects |
3 |
gradient boosting |
3 |
great britain - epidemiology |
3 |
growth |
3 |
h2ra |
3 |
healthcare dataset |
3 |
height |
3 |
helicobacter infections - complications |
3 |
helicobacter infections - diagnosis - immunology |
3 |
helicobacter infections - drug therapy |
3 |
hospitalization - statistics & numerical data |
3 |
human growth hormone - blood |
3 |
immune function |
3 |
immunotherapy |
3 |
infancy |
3 |
infant, newborn - physiology |
3 |
infection |
3 |
inflammation |
3 |
insulin-like growth factor binding protein 3 - blood |
3 |
insulin-like growth factor i - metabolism |
3 |
interleukin-6 |
3 |
interleukin-8 |
3 |
intrauterine growth retardation |
3 |
ipilimumab |
3 |
lung disease burden |
3 |
lung function |
3 |
lung volume measurements |
3 |
lymph-node metastasis |
3 |
machine learning |
3 |
machine learning algorithms |
3 |
magnifying endoscopy |
3 |
mannose-binding protein |
3 |
maximal expiratory flow rate |
3 |
metoclopramide |
3 |
monotherapy |
3 |
mutations |
3 |
nchs |
3 |
neoplasm staging |
3 |
nicotine |
3 |
nicotine - toxicity |
3 |
nicotinic acetylcholine receptor |
3 |
nitrosamines - toxicity |
3 |
nivolumab |
3 |
nnk |
3 |
nutritional status |
3 |
organ size |
3 |
osteoporosis |
3 |
osteoporosis - diagnosis - physiopathology |
3 |
ovarian cancer |
3 |
ovarian neoplasms - drug therapy - immunology |
3 |
p38 mitogen-activated protein kinases - drug effects - metabolism |
3 |
parecoxib |
3 |
pembrolizumab |
3 |
plethysmography |
3 |
polymerase chain reaction - methods |
3 |
postmenopause - physiology |
3 |
postnatal growth |
3 |
prematurity |
3 |
preterm infants |
3 |
prognostic score system |
3 |
propranolol - pharmacology |
3 |
proton pumps - antagonists & inhibitors |
3 |
pulmonary disease, chronic obstructive - blood - physiopathology |
3 |
random forest |
3 |
ranitidine - analogs & derivatives - therapeutic use |
3 |
receptors, adrenergic, beta - drug effects - metabolism |
3 |
receptors, nicotinic - drug effects - metabolism |
3 |
research design |
3 |
residual volume |
3 |
respiratory tract diseases - epidemiology - mortality |
3 |
sensitivity and specificity |
3 |
sex factors |
3 |
signal transduction - drug effects |
3 |
smoking - blood |
3 |
spirometry |
3 |
stomach neoplasms - metabolism |
3 |
surgical injury |
3 |
total lung capacity |
3 |
traditional chinese medicine |
3 |
vaccines |
3 |
vital capacity |
3 |
β-adrenergic receptor |
3 |
2-cl-ib-meca |
2 |
5-ht |
2 |
610.72 s93 |
2 |
abstracting, bibliographies, statistics statistics |
2 |
acne vulgaris - physiopathology |
2 |
adenoma |
2 |
adenoma - epidemiology |
2 |
adenosine a3 receptor |
2 |
administration, intranasal |
2 |
adverse outcomes |
2 |
aerospace medicine |
2 |
allergic thiniris |
2 |
allergy |
2 |
allied health personnel - standards |
2 |
analysis of variance |
2 |
animals |
2 |
animals, newborn |
2 |
anti-bacterial agents |
2 |
anti-inflammatory agents, non-steroidal - administration & dosage - pharmacology |
2 |
anti-ulcer agents - diagnostic use - therapeutic use |
2 |
antibiotic |
2 |
antibodies, viral - blood |
2 |
anticarcinogenic agents - administration & dosage - pharmacology |
2 |
apixaban |
2 |
apoptosis - physiology |
2 |
area under the curve |
2 |
aryl hydrocarbon receptor |
2 |
asthma |
2 |
asthma - epidemiology |
2 |
axilla |
2 |
azathioprine |
2 |
balloon dilation |
2 |
birth weight - physiology |
2 |
blood coagulation |
2 |
blood pressure - physiology |
2 |
breast - growth & development |
2 |
c-fos |
2 |
capsule endoscopy |
2 |
carcinoma |
2 |
carcinoma, squamous cell - mortality - pathology - surgery - therapy |
2 |
cardia |
2 |
catch-down growth posttreatment |
2 |
chemopreventive agents |
2 |
chest pain - etiology |
2 |
cholangitis - pathology |
2 |
clinical trials -- standards -- china |
2 |
cochrane library |
2 |
colon - innervation - metabolism - physiopathology |
2 |
colonic polyps - epidemiology |
2 |
colorectal neoplasms - epidemiology |
2 |
congenital heart disease |
2 |
consensus |
2 |
cytomegalovirus (cmv) |
2 |
cytomegalovirus - genetics - immunology |
2 |
deep learning |
2 |
developing country |
2 |
dexmedetomidine - administration and dosage |
2 |
diabetes mellitus |
2 |
diagnostic techniques, digestive system |
2 |
diarrhea - pathology - virology |
2 |
disease models, animal |
2 |
dissection |
2 |
dna, viral - blood |
2 |
dnaemia |
2 |
dtl/ramp |
2 |
dyspepsia - drug therapy |
2 |
eczema |
2 |
eczema - epidemiology |
2 |
edoxaban |
2 |
elderly-onset |
2 |
endoscopy |
2 |
endoscopy, gastrointestinal - methods |
2 |
enteritis - pathology - virology |
2 |
enterochromaffin-like cells |
2 |
ethnic contrast |
2 |
ethnicity |
2 |
factor v |
2 |
factor v - genetics - metabolism |
2 |
fbln1 |
2 |
feces - virology |
2 |
fetal growth |
2 |
final height |
2 |
foetal growth retardation |
2 |
follow-up |
2 |
gastric neoplasia |
2 |
gastrin |
2 |
gastroesophageal reflux - complications - diagnosis - drug therapy |
2 |
gene expression |
2 |
gestational age |
2 |
groin |
2 |
growth and development |
2 |
growth determination |
2 |
growth dynamics |
2 |
growth evaluation |
2 |
growth faltering |
2 |
growth hormone |
2 |
growth pattern |
2 |
growth phase |
2 |
gut microbiota |
2 |
h pylori eradication |
2 |
h. pylori |
2 |
hair - growth & development |
2 |
herpesviridae infections - blood - immunology - virology |
2 |
herpesvirus 6, human - genetics - immunology |
2 |
herpesvirus 7, human - genetics - immunology |
2 |
heterozygote |
2 |
human herpesvirus 6 (hhv6) and 7 (hhv7) |
2 |
hypnotics and sedatives - administration and dosage |
2 |
ibd |
2 |
immobilization |
2 |
immobilization - physiology |
2 |
immunohistochemistry |
2 |
infant mortality |
2 |
infantile diarrhoea |
2 |
infants |
2 |
inflammatory bowel diseases |
2 |
intensive care units |
2 |
irritable bowel syndrome - diagnosis - therapy |
2 |
irritable bowel syndrome - metabolism - physiopathology |
2 |
isaac |
2 |
kaplan-meier estimate |
2 |
kidney transplantation - adverse effects |
2 |
knemometry |
2 |
l2dtl |
2 |
leukocytes, mononuclear - immunology - virology |
2 |
linear growth |
2 |
longitudinal follow-up |
2 |
longitudinal study |
2 |
low dose |
2 |
lower leg length |
2 |
lung - physiology |
2 |
maternal deprivation |
2 |
maternal smoking |
2 |
measuring error |
2 |
medicine, chinese traditional - standards |
2 |
menarche - physiology |
2 |
monitoring, physiologic - methods |
2 |
motor development |
2 |
natural history |
2 |
neck |
2 |
neck dissection - methods |
2 |
neonatal maternal separation |
2 |
neonatal mortality |
2 |
neoplasm recurrence, local - mortality - pathology |
2 |
nf-kappa b |
2 |
non-gh deficient |
2 |
non-ulcer dyspepsia |
2 |
novel anticoagulants |
2 |
nuclear proteins - genetics - metabolism |
2 |
obesity |
2 |
observation - methods |
2 |
observer variation |
2 |
odds ratio |
2 |
oncogene |
2 |
p21 |
2 |
p53 |
2 |
pain threshold |
2 |
pakistan |
2 |
patient selection |
2 |
peptic ulcer - microbiology |
2 |
peptic ulcer disease |
2 |
peripheral blood leukocytes |
2 |
physical examination |
2 |
polymerase chain reaction (pcr) |
2 |
polyps |
2 |
post-campaign |
2 |
postneonatal deaths |
2 |
postneonatal mortality |
2 |
posture |
2 |
posture - physiology |
2 |
ppis |
2 |
prediction |
2 |
pregnancy |
2 |
premedication - methods |
2 |
prenatal growth |
2 |
preschool |
2 |
pressure |
2 |
primary teeth emergence |
2 |
probability |
2 |
proportionality |
2 |
proto-oncogene proteins c-fos - metabolism |
2 |
proton pump inhibition |
2 |
proximal colonic cancer |
2 |
puberty - physiology |
2 |
race |
2 |
randomized |
2 |
randomized controlled trials as topic |
2 |
raphe nuclei - metabolism |
2 |
rats |
2 |
rats, sprague-dawley |
2 |
receptors, serotonin, 5-ht3 - genetics - metabolism |
2 |
references (31) view in table layout |
2 |
reflex - physiology |
2 |
renal allograft |
2 |
rhinitis |
2 |
rhinitis, allergic, perennial - epidemiology |
2 |
rna, viral - analysis |
2 |
sars virus - genetics - isolation & purification |
2 |
seasonality |
2 |
serological responses |
2 |
serotonin |
2 |
serotonin - metabolism |
2 |
serotonin plasma membrane transport proteins - genetics - metabolism |
2 |
serrated lesion |
2 |
sessile serrated adenoma/polyp |
2 |
severe acute respiratory syndrome - complications - pathology |
2 |
severe acute respiratory syndrome - epidemiology - prevention & control - transmission |
2 |
sex characteristics |
2 |
short for gestational age |
2 |
short stature |
2 |
short term |
2 |
shortness |
2 |
sids |
2 |
size at birth |
2 |
small for gestational age |
2 |
socioeconomic factors |
2 |
soft tissue |
2 |
spinal cord - metabolism |
2 |
steroid-dependent ulcerative colitis |
2 |
stomach neoplasms - epidemiology - microbiology - prevention & control |
2 |
stomach neoplasms - genetics - metabolism |
2 |
stress, psychological - metabolism - physiopathology |
2 |
surveillance |
2 |
sweden |
2 |
systematic reviews as topic |
2 |
target height |
2 |
temperature |
2 |
tongue |
2 |
tongue neoplasms - mortality - pathology - surgery - therapy |
2 |
tooth, deciduous - growth & development |
2 |
transplantation, homologous |
2 |
transportation - statistics & numerical data |
2 |
travel |
2 |
treatment |
2 |
tumour suppressor gene |
2 |
tumourigenesis |
2 |
twins |
2 |
urban population |
2 |
urbanization |
2 |
venous thrombosis |
2 |
venous thrombosis - epidemiology |
2 |
venous thrombosis - genetics |
2 |
visceral hyperalgesia |
2 |
vital capacity - physiology |
2 |
world health |
2 |
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage - therapeutic use |
1 |
3' untranslated regions - genetics |
1 |
3′-untranslated region |
1 |
5- aminosalicylic acid |
1 |
570.7205 k18 |
1 |
abdominal pain - etiology |
1 |
abo blood-group system - genetics |
1 |
acid suppression |
1 |
actins - genetics - metabolism |
1 |
acute diarrhoea |
1 |
adalimumab |
1 |
adaptor proteins, signal transducing |
1 |
adenocarcinoma - blood - diagnosis - genetics |
1 |
adenocarcinoma - blood - metabolism - pathology |
1 |
adenocarcinoma - chemistry - metabolism - pathology |
1 |
adenocarcinoma - drug therapy - pathology |
1 |
adenocarcinoma - enzymology - genetics - pathology - surgery |
1 |
adenocarcinoma - enzymology - microbiology - pathology |
1 |
adenocarcinoma - genetics |
1 |
adenocarcinoma - genetics - metabolism |
1 |
adenocarcinoma - genetics - microbiology |
1 |
adenocarcinoma - microbiology |
1 |
adenocarcinoma - pathology - prevention & control |
1 |
adenoma - diagnosis |
1 |
adenoma - epidemiology - pathology |
1 |
adenoma - genetics - pathology |
1 |
adenoma detection rate |
1 |
adenosine triphosphatases |
1 |
adhesins, bacterial |
1 |
adiposity rebound |
1 |
adolescence |
1 |
adoption |
1 |
adoption - ethnology |
1 |
adriamycin |
1 |
adult overweight |
1 |
age at phv |
1 |
aging - physiology |
1 |
agranulocytosis |
1 |
agranulocytosis - chemically induced |
1 |
agriculture |
1 |
air |
1 |
alanine transaminase - blood |
1 |
alcohol drinking |
1 |
allergens |
1 |
amino acid sequence |
1 |
amino acid substitution |
1 |
amoxicillin - administration & dosage - therapeutic use |
1 |
amoxicillin - therapeutic use |
1 |
ampicillin - administration & dosage |
1 |
anabolic agents - therapeutic use |
1 |
anemia, iron-deficiency - etiology |
1 |
angiodysplasia - diagnosis |
1 |
angiogenesis |
1 |
angiogenesis inhibitors - pharmacology |
1 |
angiography |
1 |
angiopoietin |
1 |
angiopoietin-1 - genetics |
1 |
annexin a5 - pharmacology |
1 |
antacids - therapeutic use |
1 |
anti-bacterial agents - administration & dosage |
1 |
anti-bacterial agents - administration & dosage - therapeutic use |
1 |
anti-bacterial agents - pharmacology |
1 |
anti-bacterial agents - pharmacology - therapeutic use |
1 |
anti-bacterial agents - therapeutic use |
1 |
anti-hiv agents - therapeutic use |
1 |
anti-infective agents - administration & dosage |
1 |
anti-inflammatory agents |
1 |
anti-inflammatory agents, non-steroidal - administration & dosage - adverse effects - therapeutic use |
1 |
anti-inflammatory agents, non-steroidal - adverse effects |
1 |
anti-inflammatory agents, non-steroidal - adverse effects - therapeutic use |
1 |
anti-inflammatory agents, non-steroidal - pharmacology - therapeutic use |
1 |
anti-inflammatory agents, non-steroidal - therapeutic use |
1 |
anti-ulcer agents - administration & dosage |
1 |
anti-ulcer agents - administration & dosage - therapeutic use |
1 |
anti-ulcer agents - adverse effects - therapeutic use |
1 |
antibiotics, antineoplastic - pharmacology |
1 |
antibodies, antineutrophil cytoplasmic - analysis |
1 |
antibodies, bacterial - analysis |
1 |
antibodies, fungal - analysis |
1 |
antibodies, viral - diagnostic use |
1 |
antigens, bacterial |
1 |
antigens, bacterial - analysis |
1 |
antigens, bacterial - genetics |
1 |
antigens, bacterial - immunology |
1 |
antigens, cd34 - biosynthesis |
1 |
antigens, surface - genetics - metabolism |
1 |
antimetabolites, antineoplastic - pharmacology |
1 |
antineoplastic agents - administration & dosage |
1 |
antineoplastic agents - pharmacology |
1 |
antineoplastic agents - therapeutic use |
1 |
antiparasitic agents - therapeutic use |
1 |
antisense |
1 |
antiviral agents - therapeutic use |
1 |
apgar score |
1 |
apoptosis |
1 |
apoptosis - drug effects |
1 |
apoptosis - drug effects - genetics |
1 |
apoptosis regulatory proteins |
1 |
arthritis - drug therapy |
1 |
asia - epidemiology |
1 |
asia - ethnology |
1 |
asia, southeastern - epidemiology |
1 |
asphyxia neonatorum - mortality |
1 |
aspirin - administration & dosage - adverse effects |
1 |
aspirin - adverse effects |
1 |
aspirin - adverse effects - therapeutic use |
1 |
atrophy |
1 |
au-rich element |
1 |
autoimmunity |
1 |
azacitidine |
1 |
azacitidine - pharmacology |
1 |
bacteraemia |
1 |
bacteremia - diagnosis - metabolism - microbiology |
1 |
bacteremia - drug therapy |
1 |
bacteremia - drug therapy - etiology - transmission |
1 |
bacterial proteins - genetics |
1 |
bacterial vaccines |
1 |
bacteriological techniques - statistics & numerical data |
1 |
base pair mismatch |
1 |
base pair mismatch - genetics |
1 |
base sequence |
1 |
bcl2 |
1 |
benn index |
1 |
benzamides - administration & dosage - pharmacology |
1 |
benzodiazepines |
1 |
beta catenin |
1 |
bilirubin |
1 |
biologics |
1 |
biopsy |
1 |
biopsy, needle |
1 |
biosimilar |
1 |
birth |
1 |
birth defects |
1 |
birth length |
1 |
birth register |
1 |
birth weight |
1 |
birthweight |
1 |
bismuth - administration & dosage |
1 |
bismuth - administration & dosage - therapeutic use |
1 |
bites, human |
1 |
bivalvia - microbiology |
1 |
blotting, southern |
1 |
blotting, western |
1 |
body height - genetics |
1 |
body height - physiology |
1 |
body mass index reference values |
1 |
box transformation |
1 |
breast feeding |
1 |
breastfeeding |
1 |
breath tests |
1 |
bromocriptine |
1 |
bromocriptine - therapeutic use |
1 |
buffers |
1 |
butanones - therapeutic use |
1 |
cadherins - biosynthesis - genetics - metabolism |
1 |
cadherins - genetics |
1 |
cadherins - genetics - metabolism |
1 |
cadherins - metabolism |
1 |
cadmium - pharmacology |
1 |
calcium-calmodulin-dependent protein kinases - genetics |
1 |
calcium-calmodulin-dependent protein kinases - metabolism |
1 |
caliciviridae infections - classification - epidemiology - genetics |
1 |
caliciviridae infections - epidemiology - transmission - virology |
1 |
caliciviridae infections - virology |
1 |
capsid |
1 |
capsule endoscopy - methods |
1 |
capsules |
1 |
carbon isotopes - diagnostic use |
1 |
carcinoma - enzymology |
1 |
carcinoma - epidemiology - pathology |
1 |
carcinoma - genetics |
1 |
carcinoma - genetics - pathology |
1 |
carcinoma, hepatocellular - blood supply - enzymology - virology |
1 |
carcinoma, hepatocellular - drug therapy - pathology |
1 |
carcinoma, hepatocellular - metabolism - pathology |
1 |
carcinoma, small cell |
1 |
cardiovascular diseases - prevention & control |
1 |
carrier proteins |
1 |
carrier proteins - biosynthesis - metabolism |
1 |
carrier proteins - genetics - metabolism |
1 |
case mortality |
1 |
caspase 3 |
1 |
caspases - metabolism |
1 |
catalase |
1 |
catalase - metabolism |
1 |
catatonia - diagnosis - drug therapy - psychology |
1 |
ccl4 |
1 |
cecum |
1 |
ceftazidime - administration & dosage |
1 |
celecoxib |
1 |
cell culture techniques |
1 |
cell culture techniques - methods |
1 |
cell cycle |
1 |
cell cycle proteins |
1 |
cell division |
1 |
cell division - drug effects |
1 |
cell kinetics |
1 |
cell line |
1 |
cell proliferation |
1 |
cell transformation, neoplastic |
1 |
cell transformation, neoplastic - genetics |
1 |
cell viability assay |
1 |
cells, cultured |
1 |
chemokines - metabolism |
1 |
chemoprevention - methods |
1 |
chemotaxis |
1 |
child care practices |
1 |
child development - physiology |
1 |
child growth |
1 |
childhood onset of growth |
1 |
cholangiopancreatography, endoscopic retrograde - methods |
1 |
choledocholithiasis - complications - diagnosis |
1 |
cholestasis, extrahepatic - diagnosis - etiology |
1 |
choline deficiency |
1 |
chromatin remodeling |
1 |
chromatography, high pressure liquid |
1 |
chromosomal proteins, non-histone - biosynthesis |
1 |
chronic hepatitis b |
1 |
chronic renal failure |
1 |
chronic ulcerative colitis |
1 |
cirrhosis |
1 |
cisplatin - therapeutic use |
1 |
clarithromycin |
1 |
clarithromycin - administration & dosage - therapeutic use |
1 |
clarithromycin - pharmacology |
1 |
clarithromycin - pharmacology - therapeutic use |
1 |
clarithromycin - therapeutic use |
1 |
clarithromycin-containing triple therapy |
1 |
clinical competence |
1 |
clinical outcomes |
1 |
clinical stool specimens |
1 |
clinical trials - methods |
1 |
clinical trials as topic |
1 |
clinical trials as topic - methods |
1 |
clinicopathologic features |
1 |
clobetasol - adverse effects |
1 |
clostridium difficile |
1 |
cloxacillin |
1 |
cloxacillin - adverse effects |
1 |
coagulability |
1 |
colitis |
1 |
colitis, ulcerative |
1 |
colitis, ulcerative - complications - diagnosis - drug therapy - epidemiology - therapy |
1 |
colitis, ulcerative - complications - epidemiology - pathology - surgery |
1 |
colon - pathology |
1 |
colon cancer detection |
1 |
colonic neoplasms - diagnosis |
1 |
colonic polyps - diagnosis |
1 |
colonoscopes |
1 |
colonoscopy - adverse effects |
1 |
colonoscopy - methods |
1 |
colonoscopy - statistics & numerical data |
1 |
colorectal lesion |
1 |
colorectal neoplasms - complications - epidemiology - ethnology - pathology |
1 |
colorectal neoplasms - diagnosis |
1 |
colorectal neoplasms - diagnosis - enzymology |
1 |
colorectal neoplasms - diagnosis - ethnology |
1 |
colorectal neoplasms - epidemiology - mortality |
1 |
colorectal neoplasms - etiology |
1 |
colorectal neoplasms - genetics |
1 |
colorectal neoplasms - genetics - pathology |
1 |
colorectal neoplasms - pathology |
1 |
coloring agents |
1 |
combined modality therapy |
1 |
comet assay |
1 |
common bile duct |
1 |
community-based |
1 |
comparison |
1 |
confidence intervals |
1 |
congresses as topic |
1 |
connective tissue growth factor |
1 |
continuing |
1 |
cooking and eating utensils |
1 |
covid‐19 |
1 |
cpg islands |
1 |
crohn |
1 |
crohn disease |
1 |
crohn disease - classification - pathology - surgery |
1 |
crohn disease - complications - immunology |
1 |
culture |
1 |
culture media |
1 |
cyanoacrylates - diagnostic use |
1 |
cyclin d1 - analysis - biosynthesis |
1 |
cyclin d2 |
1 |
cyclin-dependent kinase inhibitor p15 |
1 |
cyclin-dependent kinase inhibitor p16 - metabolism |
1 |
cyclin-dependent kinase inhibitor p21 |
1 |
cyclin-dependent kinases - metabolism |
1 |
cyclins - biosynthesis |
1 |
cyclins - metabolism |
1 |
cyclo-oxygenase-2 |
1 |
cyclooxygenase 1 |
1 |
cyclooxygenase 2 |
1 |
cyclooxygenase 2 - analysis |
1 |
cyclooxygenase 2 - analysis - metabolism |
1 |
cyclooxygenase 2 - genetics |
1 |
cyclooxygenase 2 - genetics - metabolism |
1 |
cyclooxygenase 2 - genetics - metabolism - physiology |
1 |
cyclooxygenase 2 inhibitors |
1 |
cyclooxygenase 2 inhibitors - pharmacology |
1 |